3Q RESULTS: Bayer raises guidance as pharma sales rocket 10%
This article was originally published in Scrip
Executive Summary
After a successful third quarter, Bayer has raised its full-year sales guidance by 6%, with much of the growth coming from the company's pharmaceuticals business.